English Polski
Vol 18, No 2 (2023)
Original paper
Published online: 2023-03-22

open access

Page views 2018
Article views/downloads 235
Get Citation

Connect on Social Media

Connect on Social Media

Electronic measurement of medication adherence in patients with heart failure

Maciej Nadel1, Robert Morawiec1, Oliwia Matuszewska-Brycht1, Jarosław Drożdż1
Folia Cardiologica 2023;18(2):59-64.


Introduction. Heart failure (HF) is a significant clinical and socioeconomic problem both in Poland and around the world. However, objective data on the level of adherence in the era of improved medical therapy is lacking. Therefore, the aim of the study was to investigate the level of medication adherence and its association with demographical and clinical variables in patients with HF. Material and methods. We have conducted a prospective cohort study of 25 patients with diagnosed HF. Medication adherence was measured for 30 consecutive days using the Medication Event Monitoring System (MEMS) — an electronic cap attached to the medication container, allowing to record the exact moment of taking the measured medicine. Based on the acquired data, patients were classified as adherent or non-adherent using an evidence-based cut-point. In addition to adherence measurement, patients’ demographic and clinical information was collected. Results. Twenty-two patients provided full results from the MEMS devices. The median age of the patients was 70 years (interquartile range =14), and the mean left ventricular ejection fraction was 33% ± 12. The mean percentage of correct doses was 89% ± 17. Twenty-seven percent of patients (n = 6) were classified as non-adherent. Patients classified as non-adherent were significantly younger (54 vs. 71 years; p = 0.015), had a lower left ventricular ejection fraction (24 vs. 36%; p = 0.04), and were more frequently enrolled after HF hospitalization (83 vs. 19%; p = 0.011). Conclusions. In the short-term observation, a significant proportion of patients with HF were found to be non-adherent. In our study, we identified a population with an increased risk of non-adherence. Those patients require the implementation of more intensive and targeted healthcare system-based interventions in order to improve their prognosis.

Article available in PDF format

View PDF Download PDF file


  1. McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
  2. Kałużna-Oleksy M, et al. Niewydolność serca w Polsce. Realia, koszty, sugestie poprawy sytuacji. https://www.innowo.org/_files/ugd/5ab4e5_67ca3df8b46143f2be4d3cd34077afce.pdf (7.01.2023).
  3. Maps of Heath Needs. System and Implementation Analysis Database Platform. Epidemiology. https://basiw.mz.gov.pl/mapy-informacje/mapa-2022-2026/analizy/epidemiologia (7.01.2023).
  4. McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014; 371(11): 993–1004.
  5. Packer M, Anker SD, Butler J, et al. EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020; 383(15): 1413–1424.
  6. Komajda M, Schöpe J, Wagenpfeil S, et al. QUALIFY Investigators. Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2019; 21(7): 921–929.
  7. Ruppar TM, Cooper PS, Mehr DR, et al. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016; 5(6): e002606.
  8. Riles EM, Jain AV, Fendrick AM. Medication adherence and heart failure. Curr Cardiol Rep. 2014; 16(3): 458.
  9. Kardas P. COMPASS Investigators. Comparison of once daily versus twice daily oral nitrates in stable angina pectoris. Am J Cardiol. 2004; 94(2): 213–216.
  10. van Onzenoort HAW, Verberk WJ, Kroon AA, et al. Electronic monitoring of adherence, treatment of hypertension, and blood pressure control. Am J Hypertens. 2012; 25(1): 54–59.
  11. Wu JR, Moser DK. Health-related quality of life is a mediator of the relationship between medication adherence and cardiac event-free survival in patients with heart failure. J Card Fail. 2021; 27(8): 848–856.
  12. Wu JR, Moser DK, De Jong MJ, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009; 157(2): 285–291.
  13. Nieuwenhuis MMW, Jaarsma T, van Veldhuisen DJ, et al. Self-reported versus 'true' adherence in heart failure patients: a study using the Medication Event Monitoring System. Neth Heart J. 2012; 20(7–8): 313–319.
  14. Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005; 366(9502): 2005–2011.
  15. Jelínek L, Václavík J, Ramík Z, et al. Directly measured adherence to treatment in chronic heart failure: LEVEL-CHF registry. Am J Med Sci. 2021; 361(4): 491–498.
  16. Rezaei S, Vaezi F, Afzal G, et al. Medication adherence and health literacy in patients with heart failure: a cross-sectional survey in Iran. Health Lit Res Pract. 2022; 6(3): e191–e199.
  17. Kubica A, Kosobucka A, et al. The Adherence in Chronic Diseases Scale — a new tool to monitor implementation of a treatment plan. Folia Cardiol. 2017; 12(1): 19–26.
  18. Gupta P, Patel P, Štrauch B, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017; 69(6): 1113–1120.
  19. Pietrzykowski Ł, Michalski P, Kosobucka A, et al. Medication adherence and its determinants in patients after myocardial infarction. Sci Rep. 2020; 10(1): 12028.
  20. Gutierrez MM, Sakulbumrungsil R. Factors associated with medication adherence of hypertensive patients in the Philippines: a systematic review. Clin Hypertens. 2021; 27(1): 19.
  21. Kim SJ, Kwon OhD, Han EB, et al. Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study. Medicine (Baltimore). 2019; 98(49): e17825.
  22. Krueger K, Botermann L, Schorr SG, et al. Age-related medication adherence in patients with chronic heart failure: A systematic literature review. Int J Cardiol. 2015; 184: 728–735.
  23. Jankowska-Polańska B, Świątoniowska-Lonc N, Sławuta A, et al. Patient-reported compliance in older age patients with chronic heart failure. PLoS One. 2020; 15(4): e0231076.
  24. Wakai E, Ikemura K, Kato C, et al. Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension. PLoS One. 2021; 16(6): e0252944.
  25. Park LG, Howie-Esquivel J, Dracup K. Electronic measurement of medication adherence. West J Nurs Res. 2015; 37(1): 28–49.